Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$8,576,085
+$1,549,886 QoQ
Shares Held
67,881
+34.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#458
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $242,744,034 across 9 Drug Manufacturers - General names. GILD ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
452,664 | $58,167,324 | |
| 2 | JNJ |
Johnson & Johnson
|
211,287 | $53,660,559 | |
| 3 | ABBV |
AbbVie Inc.
|
146,723 | $36,921,375 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
558,264 | $32,167,171 | |
| 5 | PFE |
Pfizer Inc
|
1,137,828 | $27,398,898 | |
| 6 | LLY |
ELI LILLY & Co
|
14,911 | $17,884,702 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
67,881 | $8,576,085 | |
| 8 | AMGN |
Amgen Inc
|
20,994 | $7,602,347 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,576,085 | 67,881 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $7,026,199 | 50,414 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $6,641,584 | 54,111 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $5,984,343 | 53,913 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $2,198,552 | 19,830 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,971,631 | 17,596 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $1,607,792 | 17,406 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $25,857,345 | 308,413 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $26,954,673 | 392,868 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $25,964,781 | 354,468 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $26,755,901 | 330,279 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $26,130,903 | 348,691 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $26,051,278 | 338,021 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $28,937,280 | 348,768 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $28,036,807 | 326,579 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $25,924,420 | 420,237 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $32,788,597 | 530,474 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $24,786,785 | 416,935 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $24,402,914 | 336,082 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $23,506,341 | 336,526 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $25,158,069 | 365,351 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $24,243,230 | 375,108 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $19,747,401 | 338,953 | Shares | Defined | 2021-02-03 | |
| 2020-09-30 | $17,648,271 | 279,289 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $20,786,879 | 270,170 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $23,193,542 | 310,240 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||